Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV003405702 | SCV004123226 | benign | Hereditary thrombocytopenia and hematologic cancer predisposition syndrome | 2023-11-13 | reviewed by expert panel | curation | NM_001754.5(RUNX1):c.508+275T>G is an intronic variant with no predicted splice effect. MAF of 0.03675 (3.675%, 320/8708 alleles) in the African/African American subpopulation of the gnomADv2.1.1 cohort is >= 0.0015 (0.15%) (BA1). Variant observed in homozygous state (2) in gnomAD v2.1.1 (BP2). In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BA1, BP2 |
Gene |
RCV001534350 | SCV001751273 | likely benign | not provided | 2019-06-10 | criteria provided, single submitter | clinical testing |